litlas
ログインアカウント作成

William W. Busse

1972–2025 年に発表

別表記
William W Busse · WILLIAM W. BUSSE · WIlliam W Busse
294
論文数
67,301
被引用数
136
h 指数
285
i10 指数

被引用数

William W. Busse の年別被引用数1973 年: 被引用 1 件1974 年: 被引用 1 件1975 年: 被引用 1 件1977 年: 被引用 2 件1978 年: 被引用 1 件1981 年: 被引用 3 件1983 年: 被引用 4 件1984 年: 被引用 4 件1985 年: 被引用 2 件1986 年: 被引用 5 件1987 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 8 件1990 年: 被引用 12 件1991 年: 被引用 13 件1992 年: 被引用 26 件1993 年: 被引用 33 件1994 年: 被引用 43 件1995 年: 被引用 44 件1996 年: 被引用 64 件1997 年: 被引用 108 件1998 年: 被引用 140 件1999 年: 被引用 171 件2000 年: 被引用 214 件2001 年: 被引用 222 件2002 年: 被引用 266 件2003 年: 被引用 307 件2004 年: 被引用 260 件2005 年: 被引用 304 件2006 年: 被引用 347 件2007 年: 被引用 296 件2008 年: 被引用 377 件2009 年: 被引用 383 件2010 年: 被引用 445 件2011 年: 被引用 511 件2012 年: 被引用 543 件2013 年: 被引用 502 件2014 年: 被引用 577 件2015 年: 被引用 582 件2016 年: 被引用 573 件2017 年: 被引用 617 件2018 年: 被引用 506 件2019 年: 被引用 2,053 件2020 年: 被引用 2,192 件2021 年: 被引用 1,962 件2022 年: 被引用 1,624 件2023 年: 被引用 1,136 件2024 年: 被引用 1,554 件2025 年: 被引用 807 件2026 年: 被引用 11 件1976 年は被引用が無いため表示していません1979〜1980 年は被引用が無いため表示していません1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,913 件、この内訳の 21.8%イギリス: 引用元論文 2,111 件、この内訳の 9.4%中国: 引用元論文 1,123 件、この内訳の 5%イタリア: 引用元論文 1,078 件、この内訳の 4.8%ドイツ: 引用元論文 956 件、この内訳の 4.3%カナダ: 引用元論文 952 件、この内訳の 4.2%フランス: 引用元論文 829 件、この内訳の 3.7%オーストラリア: 引用元論文 820 件、この内訳の 3.7%オランダ: 引用元論文 771 件、この内訳の 3.4%日本: 引用元論文 707 件、この内訳の 3.1%スペイン: 引用元論文 681 件、この内訳の 3%スウェーデン: 引用元論文 601 件、この内訳の 2.7%
0%21.8%その他 30.9%

機関

分野

  • Medicine78.9%
  • Immunology and Microbiology7%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Environmental Science2%
  • Neuroscience1.4%
  • Health Professions0.9%
  • その他3.5%

トピック

  • Asthma and respiratory diseases22.6%
  • Allergic Rhinitis and Sensitization7.2%
  • Respiratory and Cough-Related Research5.3%
  • IL-33, ST2, and ILC Pathways4.5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.5%
  • Dermatology and Skin Diseases3%
  • その他53.9%

共著者

全論文

検索で開く
  1. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    著者: Mario Castro, Jonathan Corren, Ian Pavord, Jorge Máspero, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper - New England Journal of Medicine 2018 被引用: 1,929

  2. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    著者: J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T. Ferguson, William W. Busse, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Viktoría Werkström, Magnus Aurivillius, Mitchell Goldman - The Lancet 2016 被引用: 1,379

  3. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

    著者: Jean Bousquet, N. Khaltaev, Álvaro A. Cruz, Judah A. Denburg, Wytske J. Fokkens, Alkis Togias, Torsten Zuberbier, Carlos E. Baena‐Cagnani, Giorgio Walter Canonica, Chris van Weel, Ioana Agache, N Aït-Khaled, Claus Bachert, Michael S. Blaiss, С. Бонини, Louis‐Philippe Boulet, Philippe‐Jean Bousquet, Paulo Augusto Moreira Camargos, K.‐H. Carlsen, Y. Chen, Adnan Čustović, Ronald Dahl, Pascal Demoly, H. Douagui, S. R. Durham, Roy Gerth van Wijk, O. Kalayci, Michael Kaliner, Y.‐Y. Kim, M. L. Kowalski, Piotr Kuna, L. T. T. Le, Catherine Lemière, Junjie Li, Richard F. Lockey, S. Mavale‐Manuel, Eli O. Meltzer, Yousser Mohammad, Joaquim Mullol, Robert M. Naclerio, Robyn E. O’Hehir, Ken Ohta, S. Ouedraogo, S. Palkonen, Nikolaos G. Papadopoulos, Giovanni Passalacqua, R. Pawankar, Todor A. Popov, Klaus F. Rabe, J. Rosado‐Pinto, G. K. Scadding, F. Estelle R. Simons, Е. Тоскала, E. Valovirta, Paul Van Cauwenberge, De Yun Wang, Magnus Wickman, Barbara P. Yawn, Arzu Yorgancıoğlu, Osman Yusuf, Heather J. Zar, I. Annesi‐Maesano, E. D. Bateman, A. Ben Kheder, Daniel A. Boakye, J. Bouchard, Peter Burney, William W. Busse, Moira Chan‐Yeung, Niels H. Chavannes, А. Г. Чучалин, William K. Dolen, R. Emuzyte, L. Grouse, Marc Humbert, Claire Jackson, Sebastian L. Johnston, Paul K. Keith, James P. Kemp, J.‐M. Klossek, Désirée Larenas‐Linnemann, Brian J. Lipworth, Malo Jl, Gailen D. Marshall, Charles K. Naspitz, K Nékám, B. Niggemann, Ewa Niżankowska‐Mogilnicka, Yoshitaka Okamoto, Marco Orrù, P. Potter, David Price, Stuart Stoloff, Olivier Vandenplas, Giovanni Viegi, Dennis Williams - Allergy 2008 被引用: 4,703

  4. An expert consensus framework for asthma remission as a treatment goal

    著者: Andrew Menzies‐Gow, Mona Bafadhel, William W. Busse, Thomas B. Casale, Janwillem Kocks, Ian Pavord, Stanley J. Szefler, Prescott G. Woodruff, Alexander de Giorgio-Miller, Frank Trudo, Malin Fagerås, Christopher S. Ambrose - Journal of Allergy and Clinical Immunology 2019 被引用: 407

  5. Type 2 immunity in the skin and lungs

    著者: Cezmi A. Akdiş, Peter D. Arkwright, Marie‐Charlotte Brüggen, William W. Busse, Massimo Gadina, Emma Guttman‐Yassky, Kenji Kabashima, Yasutaka Mitamura, Laura Vian, Jianni Wu, Óscar Palomares - Allergy 2020 被引用: 552

  6. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    著者: Wendy C. Moore, Deborah A. Meyers, Sally E. Wenzel, W. Gerald Teague, Huashi Li, Xingnan Li, Ralph B. D’Agostino, Mario Castro, Douglas Curran‐Everett, Anne M. Fitzpatrick, Benjamin Gaston, Nizar N. Jarjour, Ronald L. Sorkness, William J. Calhoun, Kian Fan Chung, Suzy Comhair, Raed A. Dweik, Elliot Israel, Stephen P. Peters, William W. Busse, Serpil C. Erzurum, Eugene R. Bleecker - American Journal of Respiratory and Critical Care Medicine 2009 被引用: 2,124

  7. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

    著者: Helen K. Reddel, D. Robin Taylor, Eric D. Bateman, Louis‐Philippe Boulet, Homer A. Boushey, William W. Busse, Thomas B. Casale, Pascal Chanez, Paul Enright, Peter G. Gibson, Johan C. de Jongste, Huib A.M. Kerstjens, Stephen C. Lazarus, Mark L Levy, Paul M. O’Byrne, Martyn R Partridge, Ian Pavord, Malcolm R. Sears, Peter J. Sterk, Stuart Stoloff, Sean D. Sullivan, Stanley J. Szefler, Mike Thomas, Sally E. Wenzel - American Journal of Respiratory and Critical Care Medicine 2009 被引用: 1,926

  8. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis

    著者: Wendy C. Moore, Annette T. Hastie, Xingnan Li, Huashi Li, William W. Busse, Nizar N. Jarjour, Sally E. Wenzel, Stephen P. Peters, Deborah A. Meyers, Eugene R. Bleecker - Journal of Allergy and Clinical Immunology 2013 被引用: 591

  9. Exploring the Effects of Omalizumab in Allergic Asthma

    著者: Nicola A. Hanania, Sally E. Wenzel, Karin Rosén, Hsin-Ju Hsieh, Sofia Mosesova, David F. Choy, Preeti Lal, Joseph R. Arron, Jeffrey M. Harris, William W. Busse - American Journal of Respiratory and Critical Care Medicine 2013 被引用: 886

  10. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment

    著者: Jamee R. Castillo, Stephen P. Peters, William W. Busse - The Journal of Allergy and Clinical Immunology In Practice 2017 被引用: 557

  11. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

    著者: William W. Busse, Jonathan Corren, Bobby Q. Lanier, Margaret McAlary, Angel FowlerTaylor, Giovanni Della Cioppa, Andre van As, Niroo Gupta - Journal of Allergy and Clinical Immunology 2001 被引用: 1,294

  12. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

    著者: William W. Busse, Monica Kraft, Klaus F. Rabe, Yamo Deniz, Paul J. Rowe, Marcella Ruddy, Mario Castro - European Respiratory Journal 2021 被引用: 160

  13. Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma

    著者: William W. Busse, Stephen T. Holgate, Edward Kerwin, Yun Chon, JingYuan Feng, Joseph Lin, Shao‐Lee Lin - American Journal of Respiratory and Critical Care Medicine 2013 被引用: 657

  14. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

    著者: Daniel J. Jackson, Leonard B. Bacharier, Peter J. Gergen, Lisa Gagalis, Agustin Calatroni, Stephanie Wellford, Michelle A. Gill, Jeffrey R. Stokes, Andrew H. Liu, Rebecca S. Gruchalla, Robyn T. Cohen, Melanie Makhija, Gurjit K. Khurana Hershey, George O'connor, Jacqueline A. Pongracic, Michael G. Sherenian, Katherine Rivera‐Spoljaric, Edward M. Zoratti, Stephen J. Teach, Meyer Kattan, Cullen M. Dutmer, Hae Jin Kim, Carin Lamm, William J Sheehan, R. Max Segnitz, Kimberly A. Dill‐McFarland, Cynthia M. Visness, Patrice M. Becker, James E. Gern, Christine A. Sorkness, William W. Busse, Matthew C. Altman - The Lancet 2022 被引用: 147

  15. Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

    著者: Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos, John J. Condemi, Irmarie Reyes‐Rivera, Jin Zhu, Karin Rosén, Mark D. Eisner, Dennis A. Wong, William W. Busse - Annals of Internal Medicine 2011 被引用: 550

  16. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

    著者: Ian Pavord, Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Robert R. Johnson, Sivan Harel, Michel Djandji, Ledia Goga, Nora Crikelair, Paul J. Rowe, William W. Busse - The Journal of Allergy and Clinical Immunology In Practice 2022 被引用: 89

  17. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

    著者: Michel Laviolette, David Gossage, Gail M. Gauvreau, Richard Leigh, Ron Olivenstein, Rohit Katial, William W. Busse, Sally E. Wenzel, Yanping Wu, Vivekananda Datta, Roland Kolbeck, Néstor A. Molfino - Journal of Allergy and Clinical Immunology 2013 被引用: 508

  18. Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

    著者: Thomas B. Casale, Allan T. Luskin, William W. Busse, Robert S. Zeiger, Benjamin Trzaskoma, Ming Yang, Noelle M. Griffin, Bradley E. Chipps - The Journal of Allergy and Clinical Immunology In Practice 2018 被引用: 276

  19. Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis

    著者: Matthew C. Altman, Meyer Kattan, George O'connor, Ryan C. Murphy, Elizabeth Whalen, Petra LeBeau, Agustin Calatroni, Michelle A. Gill, Rebecca S. Gruchalla, Andrew H. Liu, Stephanie Lovinsky‐Desir, Jacqueline A. Pongracic, Carolyn M. Kercsmar, Gurjit K. Khurana Hershey, Edward M. Zoratti, Stephen J. Teach, Leonard B. Bacharier, Lisa M. Wheatley, Steve M. Sigelman, Peter J. Gergen, Alkis Togias, William W. Busse, James E. Gern, Daniel J. Jackson - The Lancet Planetary Health 2023 被引用: 109

  20. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    著者: William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, Gary T. Ferguson, Peter Barker, Stephanie Sproule, Richard F. Olsson, Ubaldo J. Martin, Mitchell Goldman, Anahí Yañez, Marcelo Fernández, Alberto Tolcachier, Juan Belloni, Jorge Taborda, Maria De Salvo, Jorge Máspero, Carlos Victorio, Miguel Chirino Navarta, Mónica Grilli, Pablo Alejandro Rodríguez, María Otaola, Victor Hugo Cambursano, Patricia Malamud, Ana Stok, German Arce, Osiris Roza, Fernando Scherbovsky, Pedro Carlos Elias, Maria Salazan Saez, Matthew Peters, Martin Phillips, John W. Upham, Peter G. Gibson, Francis Thien, John Aubrey Douglass, Paul Thomas, Philip G. Bardin, Dimitar Sajkov, Mark Hew, David Langton, Andreia Luisa Francisco Pez, Carlos Cézar Fritscher, Jorge Lima Hetzel, Waldo Mattos, Rafaël Stelmach, Martti Antila, Ana Luísa Godoy Fernandes, Hristo Metev, Yavor Ivanov, Aneliya Bogdanova, Ana Dancheva Markova, M Peneva, Rumyana Veselinova, Tatyana Petkova, Vanushka Petrova, E Shopova, Yuliya Ivanova, Rumyana Yotsova, Ginka Kirkova, Galina Petrova, Svetoslav Dachev, Kostadinka Sotirova, Mariyana Stoyanova, Oleg Yakov, Vanya Ilieva-Fartunova, Catherine Lemière, Michel Laviolette, William H. Yang, J Mark FitzGerald, Bonavuth Pek, William Patrick Killorn, Claude Poirier, Guy Chouinard, Lyle Melenka, Richard Leigh, Parameswaran Nair, Delbert Dorscheid, James G. Martin, Juana Pavie, Andres Rosenblut, Claudia Cartagena, Carlos Quilodran, Silvia Muñoz, Ivana Malkusova, Josef Veverka, Stanislav Holub, Jaroslav Mareš, Radovan Kozel, Daniela Kopecka, Vladimir Zindr, Pavel Cerva, Pascal Chanez, Arnaud Bourdin, Gilles Devouassoux, Camille Taillé, Frédéric de Blay, François Goupil, Christophe Leroyer, Delphine Gourcerol, T. Didi ほか 360 名 - The Lancet Respiratory Medicine 2018 被引用: 311

  21. Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions”

    著者: Wendy F. Davidson, Donald Y.M. Leung, Lisa A. Beck, M. Cecilia Berin, Mark Boguniewicz, William W. Busse, Talal A. Chatila, Raif S. Geha, James E. Gern, Emma Guttman‐Yassky, Alan D. Irvine, Brian Kim, Heidi H. Kong, Gideon Lack, Kari C. Nadeau, Julie M. Schwaninger, Angela Simpson, Eric L. Simpson, Jonathan M. Spergel, Alkis Togias, Ulrich Wahn, Robert A. Wood, Judith A. Woodfolk, Steven F. Ziegler, Marshall Plaut - Journal of Allergy and Clinical Immunology 2019 被引用: 201

  22. Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    著者: William W. Busse, Wayne J. Morgan, Peter J. Gergen, Herman Mitchell, James E. Gern, Andrew H. Liu, Rebecca S. Gruchalla, Meyer Kattan, Stephen J. Teach, Jacqueline A. Pongracic, James F. Chmiel, Suzanne Steinbach, Augustin Calatroni, Alkis Togias, Katherine M. Thompson, Stanley J. Szefler, Christine A. Sorkness - New England Journal of Medicine 2011 被引用: 870

  23. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

    著者: William W. Busse, Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh, Yamo Deniz, Naimish Patel, Sivan Harel, Paul J. Rowe, Neil M.H. Graham, Thomas G. O’Riordan, Ian Pavord - The Lancet Respiratory Medicine 2021 被引用: 142

  24. Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children

    著者: Matthew C. Altman, Michelle A. Gill, Elizabeth Whalen, Denise C. Babineau, Baomei Shao, Andrew H. Liu, Brett Jepson, Rebecca S. Gruchalla, George O'connor, Jacqueline A. Pongracic, Carolyn M. Kercsmar, Gurjit K. Khurana Hershey, Edward M. Zoratti, Christine Cole Johnson, Stephen J. Teach, Meyer Kattan, Leonard B. Bacharier, Avraham Beigelman, Steve M. Sigelman, Scott Presnell, James E. Gern, Peter J. Gergen, Lisa M. Wheatley, Alkis Togias, William W. Busse, Daniel J. Jackson - Nature Immunology 2019 被引用: 183